ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NICE does not recommend polatuzumab vedotin to treat lymphoma
March 03, 2020NICE has formed a negative opinion for Polivy (polatuzumab vedotin) in combination with rituximab and bendamustine to treat diffuse large B-cell lymphoma. -
ASH: Ibrutinib Tops Bendamustine + Rituximab for CLL
December 04, 2018For older patients with untreated chronic lymphocytic leukemia (CLL), treatment with ibrutinib alone or in combination with rituximab is associated with improved..... -
NHS England clears specialised treatments for NHS use
July 10, 2018NHS England has approved routine funding for a stream of new specialised treatments, including stroke-reducing heart implants and a life changing surgical procedure for children with cerebral palsy.
Pharma Sources Insight January 2025
